Cancer Study Cohort Recruitment

Award Date 6/1/2018
Last Date To Order 6/3/2028
Shared Ceiling $150M
Contract Type
Master IDIQ
Predecessor
Not listed
Successors

The Cancer Study Cohort Recruitment is an indefinite delivery/indefinite quantity (IDIQ) contract vehicle issued by the National Cancer Institute (NCI) designed to support a comprehensive, multi-center adult cohort study targeting 150,000-200,000 participants through integrated healthcare systems. The primary objective of this contract is to recruit health plan members, collect serial biospecimens and longitudinal data, and track participants for disease outcomes with a specific focus on cancer prevention and causation research. The master IDIQ contract provides a shared ceiling of $150 million and was originally awarded on June 1, 2018, with a last order date of June 3, 2028.

The task orders under this IDIQ have consistently been awarded to prominent non-profit healthcare providers and research institutions, including Henry Ford Health System, Kaiser Permanente, University of Chicago, and Sanford Research. These task orders typically range in value from approximately $200,000 to $24 million, with performance periods spanning 3-5 years. The task orders predominantly focus on infrastructure setup, study preparation and launch, patient recruitment, and establishing advisory boards for the Connect for Cancer Prevention Study. All task orders to date have been cost-reimbursement contracts (cost no fee or cost-plus fixed fee) without specific small business set-aside designations. The work is primarily conducted across multiple U.S. regions, leveraging the extensive patient populations and electronic health records of these integrated healthcare systems to support NCI's epidemiological research initiatives.

Generated 1/16/25, 12:13 AM